Victor Ed Yosuico Selected Research

Victor Ed Yosuico Research Topics

7	Hemorrhage 12/2021 - 01/2018
6	Neoplasms (Cancer) 12/2021 - 01/2018
5	Venous Thromboembolism 12/2021 - 01/2018
3	Pulmonary Embolism 10/2021 - 01/2018
2	Thrombocytopenia (Thrombopenia) 11/2018 - 01/2018
1	Multiple Myeloma 01/2021
1	Thromboembolism 01/2021
1	Hematoma 11/2018
1	Wounds and Injuries (Trauma) 11/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2018
1	Catheter-Related Infections 01/2018
1	Thrombosis (Thrombus) 01/2018

7	AnticoagulantsIBA 12/2021 - 01/2018
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2021 - 01/2018
4	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 01/2018
4	Fondaparinux (Arixtra)FDA Link 12/2021 - 01/2018
4	Vitamin K FDA Link 10/2021 - 01/2018
2	Tinzaparin (Innohep)FDA Link 12/2021 - 01/2018
2	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 01/2018
2	cyclo(Arg-Pro) (CI 4)IBA 10/2021 - 11/2018
2	CI 22IBA 11/2018 - 01/2018
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Thalidomide (Thalomid)FDA Link 01/2021
1	pomalidomideIBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	idraparinuxIBA 01/2018